BIOAVAILABILITY OF 14 NITROFURANTOIN PRODUCTS

被引:40
作者
MEYER, MC [1 ]
SLYWKA, GWA [1 ]
DANN, RE [1 ]
WHYATT, PL [1 ]
机构
[1] UNIV TENNESSEE,MED UNITS,COLL PHARM,DEPT MED CHEM,DIV DRUG METAB & BIOPHARM,MEMPHIS,TN 38163
关键词
D O I
10.1002/jps.2600631105
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
引用
收藏
页码:1693 / 1698
页数:6
相关论文
共 15 条
[1]   INCONSISTENCIES IN RATIONALE UNDERLYING OFFICIAL USP DISSOLUTION RATE SPECIFICATIONS FOR NITROFURANTOIN [J].
BATES, TR ;
ROSENBERG, HA ;
TEMBO, AV .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (12) :2057-2058
[2]  
Brodie BB, 1971, BIOAVAILABILITY DRUG
[3]  
CONKLIN JD, 1965, CLIN CHEM, V11, P925
[4]  
HOSSIE RD, 1973, CAN J PHARM SCI, V8, P37
[5]  
MATTOK GL, 1972, CAN J PHARM SCI, V7, P84
[6]   STUDY OF BIOAVAILABILITIES AND DISSOLUTION RATES OF COMMERCIAL TABLETS OF NITROFURANTOIN [J].
MCGILVERAY, IJ ;
MATTOK, GL ;
HOSSIE, RD .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1971, 23 :S246-+
[7]  
MCGILVERAY IJ, 1971, DEC CAN ASS RES TOX
[8]  
MCGILVERAY IJ, 1972, NOV APHA AC PHARM SC
[9]   HAZARD OF THERAPEUTIC NONEQUIVALENCY OF DRUG PRODUCTS [J].
SCHNELLER, GH .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1969, NS 9 (09) :455-+
[10]  
TURCK M, 1967, ANTIMICROBIAL AGENTS, P446